1.Zarb, P et al. (2012) The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Euro Surveillance 17, pii:20316.
2.Camargo, LF et al. (2015) Nosocomial bloodstream infections in a nationwide study: comparison between solid organ transplant patients and the general population. Transplant Infectious Disease 17, 308–313.
3.Nagao, M (2013) A multicentre analysis of epidemiology of the nosocomial bloodstream infections in Japanese university hospitals. Clinical Microbiology and Infection 19, 852–858.
4.Lopez-Cortes, LE et al. (2013) Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia. Clinical Infectious Diseases 57, 1225–1233.
5.Widmer, AF, Lakatos, B and Frei, R (2015) Strict infection control leads to low incidence of methicillin-resistant Staphylococcus aureus bloodstream infection over 20 years. Infection Control and Hospital Epidemiology 36, 702–709.
6.Kaasch, AJ et al. (2014) Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studies. The Journal of Infection 68, 242–251.
7.van Hal, SJ et al. (2012) Predictors of mortality in Staphylococcus aureus bacteremia. Clinical Microbiology Reviews 25, 362–386.
8.Lesens, O et al. (2003) Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity. Infection Control and Hospital Epidemiology 24, 890–896.
9.Melzer, M and Welch, C (2013) Thirty-day mortality in UK patients with community-onset and hospital-acquired meticillin-susceptible Staphylococcus aureus bacteraemia. The Journal of Hospital Infection 84, 143–150.
10.McGregor, JC et al. (2005) Utility of the chronic disease score and Charlson comorbidity Index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms. American Journal of Epidemiology 161, 483–493.
11.Schneeweiss, S et al. (2001) Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. American Journal of Epidemiology 154, 854–864.
12.Quan, H et al. (2011) Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. American Journal of Epidemiology 173, 676–682.
13.Fowler, VG Jr et al. (2005) Staphylococcus aureus endocarditis: a consequence of medical progress. Jama 293, 3012–3021.
14.Naber, CK et al. (2009) Clinical consensus conference: survey on gram-positive bloodstream infections with a focus on Staphylococcus aureus. Clinical Infectious Diseases 48, S260–S270.
15.Fowler, VG Jr et al. (2003) Clinical identifiers of complicated Staphylococcus aureus bacteremia. Archives of Internal Medicine 163, 2066–2072.
16.Friedman, ND et al. (2002) Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Annals of Internal Medicine 137, 791–797.
17.Dellinger, RP et al. (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Critical Care Medicine 41, 580–637.
18.Charlson, ME et al. (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of Chronic Diseases 40, 373–383.
19.Wayne, PA (2009) Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. Tenth Informational Supplement M100-S18. USA:CLSI.
20.Cheong, HS et al. (2008) Inappropriate initial antimicrobial therapy as a risk factor for mortality in patients with community-onset Pseudomonas aeruginosa bacteraemia. European Journal of Clinical Microbiology and Infectious Diseases 27, 1219–1225.
21.Lu, KJ et al. (2013) Age adjusted Charlson Co-morbidity Index is an independent predictor of mortality over long-term follow-up in infective endocarditis. International Journal of Cardiology 168, 5243–5248.
22.Akaike, H (1974) A new look at the statistical model identification. IEEE Transactions on Automatic Control 19, 716–723.
23.Lemeshow, S and Hosmer, DW Jr (1982) A review of goodness of fit statistics for use in the development of logistic regression models. American Journal of Epidemiology 115, 92–106.
24.Babyak, MA (2004) What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosomatic Medicine 66, 411–421.
25.McGregor, JC et al. (2006) Comorbidity risk-adjustment measures were developed and validated for studies of antibiotic-resistant infections. Journal of Clinical Epidemiology 59, 1266–1273.
26.Kim, J et al. (2013) Impact of a computerized alert system for bacteremia notification on the appropriate antibiotic treatment of Staphylococcus aureus bloodstream infections. European Journal of Clinical Microbiology and Infectious Diseases 32, 937–945.
27.Sharma, M, Szpunar, S and Khatib, R (2013) Validating severity of illness scoring systems in the prediction of outcomes in Staphylococcus aureus bacteremia. The American Journal of the Medical Sciences 346, 87–91.
28.Cremers, AJ et al. (2014) Effect of antibiotic streamlining on patient outcome in pneumococcal bacteraemia. The Journal of Antimicrobial Chemotherapy 69, 2258–2264.
29.Gelman, A and Carlin, J (2014) Beyond power calculations: assessing type S (sign) and type M (magnitude) errors. Perspectives on Psychological Science 9, 641–651.
30.Steyerberg, EW et al. (2018) Poor performance of clinical prediction models: the harm of commonly applied methods. Journal of Clinical Epidemiology 98, 133–143.
31.Morr, M et al. (2017) Sepsis recognition in the emergency department - impact on quality of care and outcome? BMC Emergency Medicine 17, 11.
32.Ebara, H et al. (2017) Clinical characteristics of Stenotrophomonas maltophilia Bacteremia: a regional report and a review of a Japanese case series. Internal Medicine 56, 137–142.
33.Jurisson, M et al. (2017) The impact of hip fracture on mortality in Estonia: a retrospective population-based cohort study. BMC Musculoskeletal Disorders 18, 243.